Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This Clinical Trial evaluates nasal administration of Dexamethasone as an adjuvant treatment strategy for non-critically ill hospitalized participants with SARS CoV-2 infection.
Epistemonikos ID: 0e3555644b3b8c72406c4ffc49826c7f78caccd1
First added on: Aug 15, 2020